Narrow search
Showing 1 - 10 of 868
Cover Image
Creating R&D Incentives for Medicines for Neglected Diseases : An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research
Müller-Langer, Frank - 2009
This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical...
Persistent link: https://www.econbiz.de/10013521260
Cover Image
Leading pharmaceutical innovation : how to win the life science race
Gassmann, Oliver; Schuhmacher, Alexander; Zedtwitz, … - 2018 - Third edition
of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for … cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R … expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture …
Persistent link: https://www.econbiz.de/10012397599
Cover Image
Pharma-Einkauf : Qualitätsorientierte Prozesse – Rechtliche Rahmenbedingungen – Trends
Bergmann, Andreas - 2018
an den Einkauf von Fertigarzneimitteln -- Verpackungsmitteleinkauf in der Pharmaindustrie -- Einkauf von CRO …. Zahlreiche Praxisbeispiele zeigen Besonderheiten: die komplexe Struktur des Arzneimittel- und Gesundheitsmarktes entlang der … Auswirkungen auf den Einkauf in der Pharmaindustrie, z. B. Digitalisierung, Telemedizin, personalisierte Medizin, integrierte …
Persistent link: https://www.econbiz.de/10014019602
Cover Image
Leading Pharmaceutical Innovation : Trends and Drivers for Growth in the Pharmaceutical Industry
Gassmann, Oliver (contributor);  … - 2008 - Second Edition
Persistent link: https://www.econbiz.de/10013520901
Cover Image
Risk-sharing in the Pharmaceutical Industry : The Case of Out-licensing
Reepmeyer, Gerrit (contributor) - 2006
Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of...
Persistent link: https://www.econbiz.de/10013520588
Cover Image
The Chemical and Pharmaceutical Industry in China : Opportunities and Threats for Foreign Companies
Festel, Gunter; Oels, Udo; Kreimeyer, Andreas; Zedtwitz, Max - 2005
Persistent link: https://www.econbiz.de/10013520463
Cover Image
AIDS and Aid : A Public Good Approach
Sonntag, Diana - 2010
The Challenge: A Transnational Response to HIV/AIDS -- Profiling the Provision Status of Health-Promoting Public Goods Against AIDS -- International Transfers -- Regional Constraints and HIV/AIDS -- Summary and Concluding Remarks
Persistent link: https://www.econbiz.de/10013521335
Cover Image
Patient Relationship Management : Ein CRM-Ansatz für die pharmazeutische Industrie
Hahn, Olaf (contributor); Bauer, Hans H. (contributor) - 2006
verschreibungspflichtiger Arzneimittel. Außerdem überprüft er anhand einer empirischen Untersuchung den Einfluss von über die Bereitstellung von …
Persistent link: https://www.econbiz.de/10013516566
Cover Image
Der Patentauslauf von Pharmazeutika als Herausforderung beim Management des Produktlebenszyklus
Raasch, Christina - 2010 - 2., durchgesehene und korrigierte Auflage
Einführung in das Thema -- Aktuelle Patentausläufe und die an ihnen beteiligten Unternehmen -- Theoretische und empirische Grundlagen -- Der Produktlebenszyklus von Arzneimitteln -- Die Rolle von Patenten in der pharmazeutischen Industrie -- Auswirkungen von Patentausläufen in der...
Persistent link: https://www.econbiz.de/10013517082
Cover Image
Causes of Supply Chain Disruptions : An Empirical Analysis in Cold Chains for Food and Pharmaceuticals
Brenner, Verena - 2015
60 supply chain specialists from production, distribution and retail of food and pharmaceuticals, drivers for resilience …
Persistent link: https://www.econbiz.de/10012402017